Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Thymidylate synthase expression in colon carcinomas with microsatellite instability.

Sinicrope FA, Rego RL, Halling KC, Foster NR, Sargent DJ, La Plant B, French AJ, Allegra CJ, Laurie JA, Goldberg RM, Witzig TE, Thibodeau SN.

Clin Cancer Res. 2006 May 1;12(9):2738-44.

2.

Chemotherapeutic implications in microsatellite unstable colorectal cancer.

Jo WS, Carethers JM.

Cancer Biomark. 2006;2(1-2):51-60. Review.

3.

Microsatellite instability testing and its role in the management of colorectal cancer.

Kawakami H, Zaanan A, Sinicrope FA.

Curr Treat Options Oncol. 2015 Jul;16(7):30. doi: 10.1007/s11864-015-0348-2. Review.

4.
5.

Clinical implications of microsatellite instability in sporadic colon cancers.

Sinicrope FA, Sargent DJ.

Curr Opin Oncol. 2009 Jul;21(4):369-73. doi: 10.1097/CCO.0b013e32832c94bd. Review.

6.

Thymidylate synthase expression and prognosis of patients with gastrointestinal cancers receiving adjuvant chemotherapy: a review.

Formentini A, Henne-Bruns D, Kornmann M.

Langenbecks Arch Surg. 2004 Oct;389(5):405-13. Review.

PMID:
15309542
7.

Implications of mismatch repair-deficient status on management of early stage colorectal cancer.

Kawakami H, Zaanan A, Sinicrope FA.

J Gastrointest Oncol. 2015 Dec;6(6):676-84. doi: 10.3978/j.issn.2078-6891.2015.065. Review.

8.

Challenges in the management of stage II colon cancer.

Dotan E, Cohen SJ.

Semin Oncol. 2011 Aug;38(4):511-20. doi: 10.1053/j.seminoncol.2011.05.005. Review.

9.

Clinical Significance and Prognostic Relevance of Microsatellite Instability in Sporadic Colorectal Cancer Patients.

Copija A, Waniczek D, Witkoś A, Walkiewicz K, Nowakowska-Zajdel E.

Int J Mol Sci. 2017 Jan 6;18(1). pii: E107. doi: 10.3390/ijms18010107. Review.

10.

Colon cancer: survival after curative surgery.

Link KH, Sagban TA, Mörschel M, Tischbirek K, Holtappels M, Apell V, Zayed K, Kornmann M, Staib L.

Langenbecks Arch Surg. 2005 Apr;390(2):83-93. Review.

PMID:
15455234
11.

Molecular predictive and prognostic markers in colon cancer.

Winder T, Lenz HJ.

Cancer Treat Rev. 2010 Nov;36(7):550-6. doi: 10.1016/j.ctrv.2010.03.005. Review.

PMID:
20363564
12.

DNA mismatch repair (MMR)-dependent 5-fluorouracil cytotoxicity and the potential for new therapeutic targets.

Li LS, Morales JC, Veigl M, Sedwick D, Greer S, Meyers M, Wagner M, Fishel R, Boothman DA.

Br J Pharmacol. 2009 Oct;158(3):679-92. doi: 10.1111/j.1476-5381.2009.00423.x. Review.

Items per page

Supplemental Content

Support Center